Skip to content

Multidimensional Negative Attention Bias Measurement Software Development and Test

Multidimensional Negative Attention Bias Measurement Software Development and Test

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-17014079
Enrollment
Unknown
Registered
2017-12-21
Start date
2017-12-25
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder

Interventions

Gold Standard:HAMD-17
Index test:assessment software

Sponsors

Beijing Anding Hospital Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Outpatient patients, aged 18 to 65 years old male and female; 2) Meet criteria for DSM-IV Major Depressive Disorder; 3) HAMD-17 = 17 on screening and baseline assessment; 4) Understand and willing to sign informed consent form

Exclusion criteria

Exclusion criteria: 1) Meet any other criteria for DSM-IV Disorders; 2) Suicidal risk or the third HAMD-17 item (suicide assessment) =3; 3) Alchohol or drug abuse or dependence in 6 months before screening; 4) With sever or unstable body disease, including any cardiovascular, tumor, kidney, respiratory, endocrine (including thyroid dysfunction), digestion, blood (such as bleeding tendency) or nervous system diseases; 5) Bleeding tendency or nervous system diseases; 5) except those with history of epilepsy, convulsion caused by febrile convulsion in children; 6) screened patients who had undergone psychiatric surgery in the first 1 years; 7) 3 months before the screening, electric convulsive treatment, transcranial magnetic stimulation treatment, phototherapy; 8) antipsychotic drugs, antidepressants and mood stabilizers are being used, with a baseline washout period of less than 5 half lives; 9) men and women who have fertility requirements (including men) during lactation, pregnancy or during pregnancy, as well as men and women who are unable to carry out safe and effective contraception; 10) cannot take medicine according to doctor's order; 11) participants who participated in other clinical trials within the first 3 months of screening; 12) the researchers found that patients who were not eligible for other conditions in the group.

Design outcomes

Primary

MeasureTime frame
HAMD-17;ERP;SPE, SEN, ACC, ROC;

Countries

China

Contacts

Public ContactGang Wang

Beijing Anding Hospital Capital Medical University

xlzhang1@foxmail.com+86 010-58303289

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026